Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design von Katz, Matthew H. G., Marsh, Robert, Herman, Joseph M., Shi, Qian, Collison, Eric, Venook, Alan P., Kindler, Hedy L., Alberts, Steven R., Philip, Philip, Lowy, Andrew M., Pisters, Peter W. T., Posner, Mitchell C., Berlin, Jordan D., Ahmad, Syed A.

Volltext

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors von Hong, David, Rasco, Drew, Veeder, Michael, Luke, Jason J., Chandler, Jason, Balmanoukian, Ani, George, Thomas J., Munster, Pamela, Berlin, Jordan D., Gutierrez, Martin, Mita, Alain, Wakelee, Heather, Samakoglu, Selda, Guan, Shanhong, Dimery, Isaiah, Graef, Thorsten, Borazanci, Erkut

Volltext

Recent advances in the treatment of pancreatic cancer [version 1; peer review: awaiting peer review] von Roth, Marc T, Cardin, Dana B, Berlin, Jordan D

Volltext

High Incidence of Cetuximab-Related Infusion Reactions in Tennessee and North Carolina and the Association With Atopic History von O'NEIL, Bert H, ALLEN, Robert, SPIGEL, David R, STINCHCOMBE, Thomas E, MOORE, Dominic T, BERLIN, Jordan D, GOLDBERG, Richard M

Volltext

Current Concepts in the Treatment of Resectable Pancreatic Cancer von Roth, Marc T., Berlin, Jordan D.

Volltext

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next‐Generation Sequencing P... von Johnson, Douglas B., Dahlman, Kimberly H., Knol, Jared, Gilbert, Jill, Puzanov, Igor, Means‐Powell, Julie, Balko, Justin M., Lovly, Christine M., Murphy, Barbara A., Goff, Laura W., Abramson, Vandana G., Crispens, Marta A., Mayer, Ingrid A., Berlin, Jordan D., Horn, Leora, Keedy, Vicki L., Reddy, Nishitha M., Arteaga, Carlos L., Sosman, Jeffrey A., Pao, William

Volltext

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2... von BERLIN, Jordan D, CATALANO, Paul, THOMAS, James P, KUGLER, John W, HALLER, Daniel G, AL BOWEN BENSON, III

Volltext

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group von Goey, Kaitlyn K.H., Sørbye, Halfdan, Glimelius, Bengt, Adams, Richard A., André, Thierry, Arnold, Dirk, Berlin, Jordan D., Bodoky, György, de Gramont, Aimery, Díaz-Rubio, Eduardo, Eng, Cathy, Falcone, Alfredo, Grothey, Axel, Heinemann, Volker, Hochster, Howard S., Kaplan, Richard S., Kopetz, Scott, Labianca, Roberto, Lieu, Christopher H., Meropol, Neal J., Price, Timothy J., Schilsky, Richard L., Schmoll, Hans-Joachim, Shacham-Shmueli, Einat, Shi, Qian, Sobrero, Alberto F., Souglakos, John, Van Cutsem, Eric, Zalcberg, John, van Oijen, Martijn G.H., Punt, Cornelis J.A., Koopman, Miriam

Volltext

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovori... von ROTHENBERG, Mace L, OZA, Amit M, LE BAIL, Nathalie, HALLER, Daniel G, BIGELOW, Robert H, BERLIN, Jordan D, MARSHALL, John L, RAMANATHAN, Ramesh K, HART, Lowell L, GUPTA, Sunil, GARAY, Carlos A, BURGER, Brent G

Volltext

Treatment for Pancreatic Cancer: Current Therapy and Continued Progress von Lockhart, A. Craig, Rothenberg, Mace L., Berlin, Jordan D.

Volltext

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials von Hong, David S, DuBois, Steven G, Kummar, Shivaani, Farago, Anna F, Albert, Catherine M, Rohrberg, Kristoffer S, van Tilburg, Cornelis M, Nagasubramanian, Ramamoorthy, Berlin, Jordan D, Federman, Noah, Mascarenhas, Leo, Geoerger, Birgit, Dowlati, Afshin, Pappo, Alberto S, Bielack, Stefan, Doz, François, McDermott, Ray, Patel, Jyoti D, Schilder, Russell J, Tahara, Makoto, Pfister, Stefan M, Witt, Olaf, Ladanyi, Marc, Rudzinski, Erin R, Nanda, Shivani, Childs, Barrett H, Laetsch, Theodore W, Hyman, David M, Drilon, Alexander

Volltext

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study von Naing, Aung, Powderly, John D, Nemunaitis, John J, Luke, Jason J, Mansfield, Aaron S, Messersmith, Wells A, Sahebjam, Solmaz, LoRusso, Patricia M, Garrido-Laguna, Ignacio, Leopold, Lance, Geschwindt, Ryan, Ding, Kai, Smith, Michael, Berlin, Jordan D

Volltext

Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma von ROTHENBERG, Mace L, LAFLEUR, Bonnie, LEVY, Donna E, WASHINGTON, Mary Kay, MORGAN-MEADOWS, Sherry L, RAMANATHAN, Ramesh K, BERLIN, Jordan D, BENSON, Al B, COFFEY, Robert J

Volltext

The epidermal growth factor receptor as a target for colorectal cancer therapy von Lockhart, Craig, Berlin, Jordan D.

Volltext

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement von Schwarz, Roderich E, Berlin, Jordan D, Lenz, Heinz J, Nordlinger, Bernard, Rubbia‐Brandt, Laura, Choti, Michael A

Volltext

Treatment of metastatic pancreatic adenocarcinoma: a review von Thota, Ramya, Pauff, James M, Berlin, Jordan D

Volltext

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes von Ellis, Lee M, Bernstein, David S, Voest, Emile E, Berlin, Jordan D, Sargent, Daniel, Cortazar, Patricia, Garrett-Mayer, Elizabeth, Herbst, Roy S, Lilenbaum, Rogerio C, Sima, Camelia, Venook, Alan P, Gonen, Mithat, Schilsky, Richard L, Meropol, Neal J, Schnipper, Lowell E

Volltext

Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer von Hochster, Howard S., Haller, Daniel G., de Gramont, Aimery, Berlin, Jordan D., Philip, Philip A., Moore, Malcolm J., Ajani, Jaffer A.

Volltext

Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers von Goff, Laura W, Thakkar, Nilay, Du, Liping, Chan, Emily, Tan, Benjamin R, Cardin, Dana B, McLeod, Howard L, Berlin, Jordan D, Zehnbauer, Barbara, Fournier, Chloe, Picus, Joel, Wang-Gillam, Andrea, Lee, Wooin, Lockhart, A Craig

Volltext

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer von Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez Fernandez, Elena, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.

Volltext